NCL Technology Ventures Ltd.
Venture capitalLondon · Seed–Series A · 2 people tracked
Also known as Narec Capital Limited
Find your way into NCL Technology Ventures Ltd.
Investment thesis
NCL is a specialist healthcare investor that believes the modernisation of healthcare will be one of the greatest growth drivers of the 21st century. The firm invests transformational equity capital in entrepreneurs building truly innovative technologies and companies at the forefront of transformational change in healthcare. It focuses on pioneers using innovation and technological advancement to help prevent, treat and cure a wide range of conditions, and aims to prepare its companies to succeed both clinically and commercially by applying capital and human skills to navigate the rapidly evolving sector.
Source: firm website, verified Aug 7, 2026.
Team · 2 people
from public directoriesWhat they invest in
from 9 of 11 portfolio companiesHealthtech ×7Biotech ×6Digital Health ×5Medical Devices ×3AI & Machine Learning ×2Deep Tech ×1FemTech ×1Hardware ×1
HQs:United Kingdom×4United States×3
Investments · 11 tracked
founders shown can be your intro pathBy year:2022 · 12020 · 12 dated
Ampersand provides a digital platform for remote patient monitoring and clinician communication, enabling healthcare teams to track symptoms, deliver digital therapies, and manage patient care in outpatient settings.
Digital HealthHealthtechWellness & FitnessNashville, US
Lang Aston(Executive Officer)Timothy M. Petrikin(Executive Officer, Director)J. Lang Aston(Executive Officer, Director)W. Bradley Rouse(Executive Officer, Director)
BoardJack Tyrell(Director)Philip Hertik(Director)
Co-investorsSimplyhealth Ventures
Azadyne is a UK biotech company and spin-out from Trinity College Dublin developing therapeutics based on tRNA modification and epigenetic regulation of cellular protein synthesis.
BiotechDeep Tech
Vincent KellyStephen Connonin
BoardJason Rutt
Co-investors24 Haymarket
Centauri Therapeutics develops the Alphamer platform, a proprietary antibody recruiting molecule technology designed to redirect the immune system against disease targets.
BiotechDigital HealthHealthtechMedical Devices
Co-investorsAMR Action FundBoehringer Ingelheim Venture Fund
Curesponse applies science and technology to improve cancer treatment, bringing together medical executives, scientists, and clinical and regulatory experts.
AI & Machine LearningBiotechDigital HealthHealthtech
Guy Neev(Co-Founder & CEO)inDr. Ravid Straussman(Scientific Founder)Dr. Seth Salpeter(Co-Founder & CTO)Eran Dor(CFO)
Co-investorsaMoon
Emteq Labs develops wearable technology that monitors and translates facial expressions to measure emotional and behavioral responses in real-world settings.
AI & Machine LearningDigital HealthHardwareHealthtechBrighton, GB
Dr Charles Nduka(Chief Science Officer (CSO) and founder)
Co-investorsInnovate UK
Revolo Biotherapeutics develops immunomodulatory therapies targeting allergic and immune-mediated conditions.
BiotechHealthtechMedical Devices
Jonathan Rigby(Employee #1)
Co-investors24 Haymarket
Sana Health develops an audiovisual device intended to help users improve physical recovery and mental well-being, targeting relief and more restful states of mind.
Digital HealthHealthtechMedical DevicesMental HealthLafayette, US
Richard Hanbury(Founder)in
Co-investorsCheckmate Capital Group LLCClick VenturesFlucas VenturesHarmonix FundHealthtech CapitalMarram Ventures+5 more
Developing a scalable off-the-shelf allogeneic gamma delta T cell therapy platform.
BiotechHolytown, Motherwell
Martin Thorp(Executive Officer, Director)Edward Niemczyk(Director)Mark Bonyhadi(Director)Michael Leek(Director)Arlene Morris(Director)James Culverwell(Director)
Co-investorsInvesting Women AngelsCrowdcubeScottish Enterprise
Viramal develops proprietary products for women's sexual, vaginal, and reproductive health using its Fem Med Tech platform.
BiotechFemTechHealthtech
Oliver Bates(Chief Executive Officer and Co-founder)in
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
RevoloViramel
Portfolio news
latest coverage across their companiesCentauri Therapeutics · centauritherapeutics.com · May 5, 2026
Principals & officers · per Companies House
what is this? ⓘDirector · British · since 2011
Director · British · since 2017
Ashberg Ltd — 25–50% of shares
Frequently asked questions
- How many investments has NCL Technology Ventures Ltd. made?
- NCL Technology Ventures Ltd. has 11 tracked investments.
- What stage does NCL Technology Ventures Ltd. invest at?
- NCL Technology Ventures Ltd. invests at the Seed, Series A stages.
- What sectors does NCL Technology Ventures Ltd. focus on?
- NCL Technology Ventures Ltd. focuses on Biotech, Digital Health, Enterprise Software, FemTech, Healthtech, Medical Devices, Mental Health, SaaS, Wellness & Fitness.
- Where is NCL Technology Ventures Ltd. located?
- NCL Technology Ventures Ltd. is headquartered in London, GB.
- Who does NCL Technology Ventures Ltd. co-invest with?
- NCL Technology Ventures Ltd. most often shares deals with 24 Haymarket, Click Ventures, Marram Ventures, among 13 tracked co-investors.
Similar investors
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
LongeVC is a venture capital firm backing early-stage founders in biotech and longevity, aiming to bring breakthrough science and treatments to market.
Foreground Capital is a venture capital firm dedicated to investing in the future of women's health, building on its predecessor track record at RH Capital.
WELL Health Ventures is the corporate venture arm of WELL Health Technologies, backing digital health companies with an emphasis on modernizing healthcare in Canada.
SteelSky Ventures is an AI-focused healthcare venture fund that backs companies opening new markets and advancing healthcare innovation, with an emphasis on women's health and health equity.